SA child with cerebral palsy to receive ground-breaking treatment

accreditation
Image only for illustration purposes
Image only for illustration purposes
iStock

Almost four out of every 1 000 children are born with cerebral palsy each year. While there’s currently no cure for this debilitating group of disorders, a three-year-old South African boy born with cerebral palsy has been accepted into a ground-breaking stem cell treatment programme at Duke University in the United States.

Two clinical trials

The treatment is experimental, but involves an infusion of the child’s own umbilical cord blood. The boy’s parents stored his umbilical cord at birth in Africa’s largest private stem cell bank, Netcells. Stem cells are in essence the building blocks of life and can transform into specialised cells that can regenerate or facilitate the repair of cells damaged by disease, genetics or injury. The umbilical cord is rich in haematopoietic stem cells that can be used in the treatment of cerebral palsy.

Read: Cerebral palsy

Symptoms of cerebral palsy include difficulty with fine motor tasks (such as writing or using scissors), difficulty maintaining balance or walking and involuntary movements. It is believed the treatment will aid in relieving these symptoms.  

Prof Joanna Kurtzberg from Duke University will oversee the treatment. In 1993 she was the first person to successfully perform an unrelated cord blood transplant. She has completed two clinical trials which demonstrated that the functional ability of children with cerebral palsy improved with a single intravenous infusion of a child’s own umbilical cord stem cells.

Read: Breakthrough in cerebral palsy

According to Dr Yvonne Holt, medical director of Netcells, regenerative therapies are an emerging and extremely promising area of medical science.

“In less than a generation, research into the use of umbilical cord blood stem cells is producing powerful treatments for a range of diseases and genetic disorders,” she says.

“These include over 80 blood disorders and immune system conditions such as leukaemia, anaemia and autoimmune diseases where cord blood stem cells are used to regenerate bone marrow, and there are trials underway for treatments of autism, brain injury and Type 1 diabetes.”

Prior to acceptance into the treatment programme at Duke University, both the boy and his unit of blood had to undergo various assessments. The unit has already been transported to the university and will be administered in July.

Read more:

Cerebral palsy: guide for parents

Cerebral palsy gene spotted

New clues to cerebral palsy

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Voting Booth
Have you entered our Health of the Nation survey?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes
29% - 9758 votes
No
71% - 24088 votes
Vote